Alpha Cognition receives European patent for Alzheimer's drug Zunveyl

Go back to Alpha Cognition receives European patent for Alzheimer's drug Zunveyl
(NASDAQ: ACOG) Delayed: 9.03 -0.1 (1.1%)
Previous Close $9.13    52 Week High
Open $9.21    52 Week Low
Day High $9.22    P/E N/A 
Day Low $8.89    EPS
Volume 9,163